Global, regional and national estimates of influenza-attributable ischemic heart disease mortality

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Global, regional and national estimates of influenza-attributable ischemic heart disease mortality. / Chaves, Sandra S.; Nealon, Joshua; Burkart, Katrin G.; Modin, Daniel; Biering-Sørensen, Tor; Ortiz, Justin R.; Vilchis-Tella, Victor M.; Wallace, Lindsey E.; Roth, Gregory; Mahe, Cedric; Brauer, Michael.

In: EClinicalMedicine, Vol. 55, 101740, 2023.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Chaves, SS, Nealon, J, Burkart, KG, Modin, D, Biering-Sørensen, T, Ortiz, JR, Vilchis-Tella, VM, Wallace, LE, Roth, G, Mahe, C & Brauer, M 2023, 'Global, regional and national estimates of influenza-attributable ischemic heart disease mortality', EClinicalMedicine, vol. 55, 101740. https://doi.org/10.1016/j.eclinm.2022.101740

APA

Chaves, S. S., Nealon, J., Burkart, K. G., Modin, D., Biering-Sørensen, T., Ortiz, J. R., Vilchis-Tella, V. M., Wallace, L. E., Roth, G., Mahe, C., & Brauer, M. (2023). Global, regional and national estimates of influenza-attributable ischemic heart disease mortality. EClinicalMedicine, 55, [101740]. https://doi.org/10.1016/j.eclinm.2022.101740

Vancouver

Chaves SS, Nealon J, Burkart KG, Modin D, Biering-Sørensen T, Ortiz JR et al. Global, regional and national estimates of influenza-attributable ischemic heart disease mortality. EClinicalMedicine. 2023;55. 101740. https://doi.org/10.1016/j.eclinm.2022.101740

Author

Chaves, Sandra S. ; Nealon, Joshua ; Burkart, Katrin G. ; Modin, Daniel ; Biering-Sørensen, Tor ; Ortiz, Justin R. ; Vilchis-Tella, Victor M. ; Wallace, Lindsey E. ; Roth, Gregory ; Mahe, Cedric ; Brauer, Michael. / Global, regional and national estimates of influenza-attributable ischemic heart disease mortality. In: EClinicalMedicine. 2023 ; Vol. 55.

Bibtex

@article{8455479b5f4549f98ed98ee31c34c51d,
title = "Global, regional and national estimates of influenza-attributable ischemic heart disease mortality",
abstract = "Background: Influenza virus infection is associated with incident ischemic heart disease (IHD) events. Here, we estimate the global, regional, and national IHD mortality burden attributable to influenza. Methods: We used vital registration data from deaths in adults ≥50 years (13.2 million IHD deaths as underlying cause) to assess the relationship between influenza activity and IHD mortality in a non-linear meta-regression framework from 2010 to 2019. This derived relationship was then used to estimate the global influenza attributable IHD mortality. We estimated the population attributable fraction (PAF) of influenza for IHD deaths based on the relative risk associated with a given level of weekly influenza test positivity rate and multiplied PAFs by IHD mortality from the Global Burden of Disease study. Findings: Influenza activity was associated with increased risk of IHD mortality across all countries analyzed. The mean PAF of influenza for IHD mortality was 3.9% (95% uncertainty interval [UI] 2.5–5.3%), ranging from <1% to 10%, depending on country and year. Globally, 299,858 IHD deaths (95% UI 191,216–406,809) in adults ≥50 years could be attributed to influenza, with the highest rates per 100,000 population in the Central Europe, Eastern Europe and Central Asia Region (32.3; 95% UI 20.6–43.8), and in the North Africa and Middle East Region (26.7; 95% UI 17–36.2). Interpretation: Influenza may contribute substantially to the burden of IHD. Our results suggest that if there were no influenza, an average of 4% of IHD deaths globally would not occur. Funding: Collaborative study funded by Sanofi Vaccines.",
keywords = "Cardiovascular, Global disease burden, Influenza, Ischemic heart disease, Mortality",
author = "Chaves, {Sandra S.} and Joshua Nealon and Burkart, {Katrin G.} and Daniel Modin and Tor Biering-S{\o}rensen and Ortiz, {Justin R.} and Vilchis-Tella, {Victor M.} and Wallace, {Lindsey E.} and Gregory Roth and Cedric Mahe and Michael Brauer",
note = "Publisher Copyright: {\textcopyright} 2022 The Author(s)",
year = "2023",
doi = "10.1016/j.eclinm.2022.101740",
language = "English",
volume = "55",
journal = "EClinicalMedicine",
issn = "2589-5370",
publisher = "The Lancet Publishing Group",

}

RIS

TY - JOUR

T1 - Global, regional and national estimates of influenza-attributable ischemic heart disease mortality

AU - Chaves, Sandra S.

AU - Nealon, Joshua

AU - Burkart, Katrin G.

AU - Modin, Daniel

AU - Biering-Sørensen, Tor

AU - Ortiz, Justin R.

AU - Vilchis-Tella, Victor M.

AU - Wallace, Lindsey E.

AU - Roth, Gregory

AU - Mahe, Cedric

AU - Brauer, Michael

N1 - Publisher Copyright: © 2022 The Author(s)

PY - 2023

Y1 - 2023

N2 - Background: Influenza virus infection is associated with incident ischemic heart disease (IHD) events. Here, we estimate the global, regional, and national IHD mortality burden attributable to influenza. Methods: We used vital registration data from deaths in adults ≥50 years (13.2 million IHD deaths as underlying cause) to assess the relationship between influenza activity and IHD mortality in a non-linear meta-regression framework from 2010 to 2019. This derived relationship was then used to estimate the global influenza attributable IHD mortality. We estimated the population attributable fraction (PAF) of influenza for IHD deaths based on the relative risk associated with a given level of weekly influenza test positivity rate and multiplied PAFs by IHD mortality from the Global Burden of Disease study. Findings: Influenza activity was associated with increased risk of IHD mortality across all countries analyzed. The mean PAF of influenza for IHD mortality was 3.9% (95% uncertainty interval [UI] 2.5–5.3%), ranging from <1% to 10%, depending on country and year. Globally, 299,858 IHD deaths (95% UI 191,216–406,809) in adults ≥50 years could be attributed to influenza, with the highest rates per 100,000 population in the Central Europe, Eastern Europe and Central Asia Region (32.3; 95% UI 20.6–43.8), and in the North Africa and Middle East Region (26.7; 95% UI 17–36.2). Interpretation: Influenza may contribute substantially to the burden of IHD. Our results suggest that if there were no influenza, an average of 4% of IHD deaths globally would not occur. Funding: Collaborative study funded by Sanofi Vaccines.

AB - Background: Influenza virus infection is associated with incident ischemic heart disease (IHD) events. Here, we estimate the global, regional, and national IHD mortality burden attributable to influenza. Methods: We used vital registration data from deaths in adults ≥50 years (13.2 million IHD deaths as underlying cause) to assess the relationship between influenza activity and IHD mortality in a non-linear meta-regression framework from 2010 to 2019. This derived relationship was then used to estimate the global influenza attributable IHD mortality. We estimated the population attributable fraction (PAF) of influenza for IHD deaths based on the relative risk associated with a given level of weekly influenza test positivity rate and multiplied PAFs by IHD mortality from the Global Burden of Disease study. Findings: Influenza activity was associated with increased risk of IHD mortality across all countries analyzed. The mean PAF of influenza for IHD mortality was 3.9% (95% uncertainty interval [UI] 2.5–5.3%), ranging from <1% to 10%, depending on country and year. Globally, 299,858 IHD deaths (95% UI 191,216–406,809) in adults ≥50 years could be attributed to influenza, with the highest rates per 100,000 population in the Central Europe, Eastern Europe and Central Asia Region (32.3; 95% UI 20.6–43.8), and in the North Africa and Middle East Region (26.7; 95% UI 17–36.2). Interpretation: Influenza may contribute substantially to the burden of IHD. Our results suggest that if there were no influenza, an average of 4% of IHD deaths globally would not occur. Funding: Collaborative study funded by Sanofi Vaccines.

KW - Cardiovascular

KW - Global disease burden

KW - Influenza

KW - Ischemic heart disease

KW - Mortality

UR - http://www.scopus.com/inward/record.url?scp=85142156660&partnerID=8YFLogxK

U2 - 10.1016/j.eclinm.2022.101740

DO - 10.1016/j.eclinm.2022.101740

M3 - Journal article

C2 - 36425868

AN - SCOPUS:85142156660

VL - 55

JO - EClinicalMedicine

JF - EClinicalMedicine

SN - 2589-5370

M1 - 101740

ER -

ID: 331789588